(NVLN) |
0 (0%) 04-25 16:39 |
Open: | |
High: | |
Low: | |
Volume: | 0 |
Market Cap: | 0(M) |
PE Ratio: | 0 |
Exchange: | |
Industry: | |
Sector: |
Technical analysis | ||||
sell | buy |
Resistance 2: | 2.94 |
Resistance 1: | 2.52 |
Pivot price: | 2.41 |
Support 1: | 2.19 |
Support 2: | 1.99 |
52w High: | |
52w Low: |
EPS | -0.190 |
Book Value | 1.590 |
PEG Ratio | -1.76 |
Gross Profit | 0.000 |
Profit Margin (%) | -23.36 |
Operating Margin (%) | -7.91 |
Return on Assets (ttm) | -8.9 |
Return on Equity (ttm) | -11.9 |
Fri, 10 Mar 2023
Novelion Announces Completion of Plan of Liquidation and Distribution and its Voluntary Dissolution - GlobeNewswire
Mon, 28 Mar 2022
Novelion Announces Date of Final Distribution to Registered Shareholders - GlobeNewswire
Wed, 30 Sep 2020
Novelion Therapeutics Provides Update on Liquidation Process - GlobeNewswire
Wed, 25 Sep 2019
Novelion Therapeutics Announces Completion of Aegerion Transaction and Departure of Certain Directors and Officers - GlobeNewswire
Mon, 20 May 2019
Novelion Therapeutics Announces Subsidiary Aegerion Pharmaceuticals to Recapitalize Through Court Supervised ... - GlobeNewswire
Tue, 20 Nov 2018
Novelion Therapeutics Announces Leadership Change - GlobeNewswire
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |